Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Luye Pharma's LY03004 Manufacturing Facility Successfully Passes U.S. FDA Pre-approval Inspection with Zero Observation 2019-11-05 00:39
Boehringer Ingelheim and Lilly modernise alliance to focus full expertise on Jardiance® 2019-11-04 22:00
China Biologic Products to Report Third Quarter 2019 Financial Results 2019-11-04 21:30
Healthcare Support Remains Strong For Singaporeans With Advanced Breast Cancer, But Patients Call For Greater Disease Education, Survey Finds 2019-11-04 08:15
Encore Medical Education Will Publish the Official Best of SABCS(R) News From the 2019 San Antonio Breast Cancer Symposium (SABCS(R)) Starting December 12, 2019 2019-11-01 23:00
High Performance Swine Production With Reduced Use of Antibiotics: Second Workshop by EW Nutrition and OPP Group 2019-11-01 20:22
Dachser Air & Sea Logistics certified for pharmaceutical shipments on three continents 2019-11-01 09:00
Mallinckrodt and Terumo BCT Announce UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for the Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults 2019-11-01 04:35
Seneca Biopharma to Begin Trading Under New Ticker Symbol SNCA 2019-10-31 23:00
GC Pharma Reports Q3 2019 Results 2019-10-30 21:00
Seneca Biopharma and QYuns Therapeutics Sign Term Sheet for Global Licensing of Novel Monoclonal Antibodies for Treating Auto-Immune Diseases 2019-10-30 19:00
EC Approves Astellas' XOSPATA(TM) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe's LeukoStrat(R) CDx FLT3 Mutation Assay 2019-10-30 18:00
Seneca Biopharma to Present at the 7th China Renaissance Healthcare and Life Sciences Leadership Summit 2019-10-29 13:17
European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma 2019-10-29 02:00
Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis 2019-10-28 20:30
HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH) 2019-10-28 08:38
WuXi STA's Jinshan Facility Passes EMA Inspection 2019-10-28 08:00
HistoIndex Announces Global Partnerships To Expand AI-Based Digital Pathology Platform As A Drug Discovery Tool In Preclinical Studies For Nonalcoholic Steatohepatitis (NASH) 2019-10-26 19:00
Adagene Presents Its Lead Antibody Program, ADG106, at International Conferences 2019-10-26 18:01
Fountain Medical Development Limited Announces $62 mm Series D Round Financing, Further Strengthening its Global Services Capabilities 2019-10-25 14:06
1 325 326 327 328 329 423